Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
Blog Post
September 19, 2023
Health systems in Africa are under considerable strain: rapid demographic change, rising non-communicable diseases, and emerging and re-emerging threats such as COVID-19 and Ebola are increasing demands on limited health services. The African Union’s admission to the G20 provides an opportunity for ...
Blog Post
September 19, 2023
September’s crisp fall weather is arriving, and with it, another annual United Nations General Assembly (UNGA), with thousands of people descending upon New York, buzzing about what should be the world’s priorities and objectives.
Fortunately, the world already has a set of #goals that were deve...
Blog Post
September 14, 2023
COVID-19 is fading from public discussion, countries’ , and hopes for a safer and fairer future are being dashed by potentially watered-down political commitments. Yet people around the world continue to feel the impacts of COVID-19 every day, other infectious disease threats have not magically gone...
Blog Post
September 05, 2023
Today the Africa Centers for Disease Control’s (ACDC) Health Economics Programme (HEP) has published a new policy brief on the cost-effectiveness of two COVID-19 oral antivirals (COAVs), a nirmatrelvir/ritonavir combination, developed by Pfizer and sold under the name Paxlovid, and Molnupiravir, dev...
Blog Post
August 28, 2023
We’d been eagerly awaiting an update to DFC’s downloadable project data for insight into the development finance agency’s recent investments and overarching portfolio composition. A new drop finally came earlier this month detailing transactions through FY2022 and timed with the release of DFC’s ina...
CGD NOTES
August 23, 2023
Across several African countries, there has been a troubling trend of infrastructure being stripped to sell as scrap metal. People have been arrested for ripping out and selling rail sleepers in South Africa and Ghana, pylon and copper wires in Uganda, and streetlamp meters in Liberia. That strippin...
Blog Post
August 22, 2023
A recent, thought-provoking blog by our colleague, Justin Sandefur, titled “How Economists got Africa’s AIDS Epidemic Wrong”, has sparked a debate about the historical role of cost-effectiveness analysis in assessing the investments of the President's Emergency Plan for AIDS Relief (PEPFAR) and, imp...
CGD NOTES
August 18, 2023
The World Health Organization (WHO) declared the end of the Public Health Emergency of International Concern (PHEIC) for COVID-19 on May 5 and for mpox on May 11, 2023. Throughout its use, the meaning of the PHEIC has been muddled. We call for a new, objective epidemic scale that better communicates...